← Leaderboards
Maria Arolfo
Sri International
$1,401,794
Attributed
$1,401,794
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $830.6K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,401,794 · 2
By mechanism
N01$1,401,794 · 2
Top collaborators
No co-investigators on record.
Most similar at Sri International
Same institution · by research overlap
- Polly Chang$121,906,628
- Jon Carl Mirsalis$108,012,322
- Jon Mirsalis$56,020,705
- Hanna Ng$10,741,273
- Toufan Parman$25,866,968
Others in their field
Other Rising Stars on “Rodent”
- Kevin V Grimes · Stanford University$14,783,804
- Alexander Kolykhalov · Emory University$8,116,465
- Li Liang · University Of California-Irvine$7,511,446
- Luis A Cifuentes · New Mexico State University Las Cruces$7,084,640
- Charles Daniel Meyers · Tempero Bio, Inc.$5,310,920
- Ian Gurrell · Astrazeneca Pharmaceuticals, Lp$5,256,914
Research focus
RodentNovel TherapeuticsContractsAddictionCardiovascular PhysiologyCase-By-Case BasisCanis FamiliarisClinical TrialsCocaineCollaborationsCommunitiesCongenital AbnormalityDrug DevelopmentDevicesDoseChronicDrug InteractionsDrug KineticsEvaluationExtramural ActivitiesGenotoxicityInbred Balb C MiceInvestigational DrugsBasic Science
Grant awards (2)
Pharmacokinetics of Long-Acting Preparations of Antitubercular Drugs in Rodents$830,604
N01 · FY2025 · AI · contact PI
TASK ORDER 01 COCAINE INTERACTION SAFETY STUDIES IN RATS. TOXICOLOGICAL EVALUATIONS OF POTENTIAL MEDICATIONS IDIQ. ORDERING PERIOD: 09/12/2023 - 09/11/2024. NIDA REF. NO. N01DA-23-8939$571,190
N01 · FY2023 · DA · contact PI